The Authors thank all study participants for their willingness to provide data for this research project and are indebted to all coworkers for their enthusiastic commitment.
The Gutenberg Health Study is funded through the government of Rhineland-Palatinate (“Stiftung Rheinland-Pfalz für Innovation,” contract AZ 961-386261/733), the research programs “Wissen schafft Zukunft” and “Center for Translational Vascular Biology (CTVB)” of the Johannes Gutenberg-University of Mainz, and its contract with Boehringer Ingelheim and PHILIPS Medical Systems, including an unrestricted grant for the Gutenberg Health Study. PSW is funded by the Federal Ministry of Education and Research (BMBF 01EO1503) and is Principle Investigator of the German Center for Cardiovascular Research (DZHK).
Disclosure: A.K. Schuster, Santen Pharmaceutical Co., Ltd. (F); N. Pfeiffer, Novartis (F), Ivantis (F), Santen (F), Thea (F), Boehringer Ingelheim Deutschland GmbH & Co. KG (F), Alcon (F), Sanoculis (F); S. Nickels, Novartis Pharma GmbH (R); A. Schulz, None; R. Höhn, None; P.S. Wild, Boehringer Ingelheim Deutschland GmbH & Co. KG (F), Daiichi Sankyo Deutschland GmbH (F), Bayer HealthCare-Bayer-Vital GmbH (F), Portavita BV (F), Sanofi-Aventis Deutschland GmbH (F), The German Ministry of Research (F), The Ministry of Health of Rhineland-Palatinate (F); H. Binder, None; T. Münzel, Boehringer Ingelheim Deutschland GmbH & Co. KG (R), Servier Deutschland GmbH (R), Actavis Deutschland GmbH (R), Berlin Chemie Deutschland (R), German Ministry of Research (F), Government of Rhineland-Palatinate (F); M.E. Beutel, Pfizer Deutschland GmbH (R), Shire Deutschland GmbH (R), Government of Rhineland-Palatinate (F), Government of Nordrhein-Westfalen (F), German Association of Psychoanalysis and Psychotherapy (DGPT) (F), German Research Foundation (F), German Ministry of Research (F), German Cancer Aid (F), European Union (F); U. Vossmerbaeumer, None